INTCO Medical reported revenue of RMB6.91 billion (approximately US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year earlier. Net profit attributable to shareholders increased 17.86% to RMB837.3 million (approximately US$124.6 million), while adjusted net profit excluding nonrecurring gains and losses rose 165.00% to RMB1.06 billion (approximately US$157.7 million). Annualized disposable-glove production capacity reached 107 billion pieces, comprising 74 billion nitrile gloves and 33 billion vinyl gloves. The company said the scale reinforces its position as the world's largest producer of disposable gloves. INTCO Medical's integrated value chain covers nitrile latex, core production-equipment research and manufacturing, glove production and global sales. Research and development expenses rose 20.62% to RMB245.9 million, supporting products including Syntex™ Synthetic Latex Gloves and Synmax Pro Exam Gloves. Smart manufacturing systems, including a nitrile production line spanning more than 1.6 kilometers and about 500 control points, helped maintain product yield above 99% during the reporting period.